These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 1309380)

  • 1. A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer.
    Fukuoka M; Niitani H; Suzuki A; Motomiya M; Hasegawa K; Nishiwaki Y; Kuriyama T; Ariyoshi Y; Negoro S; Masuda N
    J Clin Oncol; 1992 Jan; 10(1):16-20. PubMed ID: 1309380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I and pharmacologic study of irinotecan and etoposide with recombinant human granulocyte colony-stimulating factor support for advanced lung cancer.
    Masuda N; Fukuoka M; Kudoh S; Matsui K; Kusunoki Y; Takada M; Nakagawa K; Hirashima T; Tsukada H; Yana T
    J Clin Oncol; 1994 Sep; 12(9):1833-41. PubMed ID: 7521905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A phase II study of CPT-11, a camptothecin derivative, in patients with primary lung cancer. CPT-11 Cooperative Study Group].
    Negoro S; Fukuoka M; Niitani H; Suzuki A; Nakabayashi T; Kimura M; Motomiya M; Kurita Y; Hasegawa K; Kuriyama T
    Gan To Kagaku Ryoho; 1991 May; 18(6):1013-9. PubMed ID: 1851408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II study of CPT-11, a new camptothecin derivative, in metastatic colorectal cancer. CPT-11 Gastrointestinal Cancer Study Group.
    Shimada Y; Yoshino M; Wakui A; Nakao I; Futatsuki K; Sakata Y; Kambe M; Taguchi T; Ogawa N
    J Clin Oncol; 1993 May; 11(5):909-13. PubMed ID: 8487053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I and pharmacologic studies of the camptothecin analog irinotecan administered every 3 weeks in cancer patients.
    Abigerges D; Chabot GG; Armand JP; Hérait P; Gouyette A; Gandia D
    J Clin Oncol; 1995 Jan; 13(1):210-21. PubMed ID: 7799022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I clinical trial of irinotecan (CPT-11), 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxy-camptothecin, and cisplatin in combination with fixed dose of vindesine in advanced non-small cell lung cancer.
    Shinkai T; Arioka H; Kunikane H; Eguchi K; Sasaki Y; Tamura T; Ohe Y; Oshita F; Nishio M; Karato A
    Cancer Res; 1994 May; 54(10):2636-42. PubMed ID: 8168091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CPT-11: a new derivative of camptothecin for the treatment of refractory or relapsed small-cell lung cancer.
    Masuda N; Fukuoka M; Kusunoki Y; Matsui K; Takifuji N; Kudoh S; Negoro S; Nishioka M; Nakagawa K; Takada M
    J Clin Oncol; 1992 Aug; 10(8):1225-9. PubMed ID: 1321891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A phase I study of weekly administration of CPT-11 in lung cancer].
    Fukuoka M; Negoro S; Niitani H; Furue H; Hasegawa K; Hara Y; Hara N; Taguchi T
    Gan To Kagaku Ryoho; 1990 May; 17(5):993-7. PubMed ID: 2159268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CPT-11 in combination with cisplatin for advanced non-small-cell lung cancer.
    Masuda N; Fukuoka M; Takada M; Kusunoki Y; Negoro S; Matsui K; Kudoh S; Takifuji N; Nakagawa K; Kishimoto S
    J Clin Oncol; 1992 Nov; 10(11):1775-80. PubMed ID: 1328551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase II study of irinotecan (CPT-11) in patients with advanced squamous cell carcinoma of the cervix.
    Irvin WP; Price FV; Bailey H; Gelder M; Rosenbluth R; Durivage HJ; Potkul RK
    Cancer; 1998 Jan; 82(2):328-33. PubMed ID: 9445190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [An early phase II study of CPT-11 in primary lung cancer].
    Nakai H; Fukuoka M; Furuse K; Nakao I; Yoshimori K; Ogura T; Hara N; Sakata Y; Saito H; Hasegawa K
    Gan To Kagaku Ryoho; 1991 Apr; 18(4):607-12. PubMed ID: 1849391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A late phase II study of CPT-11, irinotecan hydrochloride, in patients with advanced pancreatic cancer. CPT-11 Study Group on Gastrointestinal Cancer].
    Sakata Y; Shimada Y; Yoshino M; Kambe M; Futatsuki K; Nakao I; Ogawa N; Wakui A; Taguchi T
    Gan To Kagaku Ryoho; 1994 Jun; 21(7):1039-46. PubMed ID: 8210255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weekly irinotecan and cisplatin in advanced non-small cell lung cancer: a multicenter phase II study.
    Jagasia MH; Langer CJ; Johnson DH; Yunus F; Rodgers JS; Schlabach LL; Cohen AG; Shyr Y; Carbone DP; Devore RF
    Clin Cancer Res; 2001 Jan; 7(1):68-73. PubMed ID: 11205920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicenter, phase II trial of weekly irinotecan (CPT-11) in patients with previously treated colorectal carcinoma.
    Rothenberg ML; Cox JV; DeVore RF; Hainsworth JD; Pazdur R; Rivkin SE; Macdonald JS; Geyer CE; Sandbach J; Wolf DL; Mohrland JS; Elfring GL; Miller LL; Von Hoff DD
    Cancer; 1999 Feb; 85(4):786-95. PubMed ID: 10091755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I study of weekly intravenous infusions of CPT-11, a new derivative of camptothecin, in the treatment of advanced non-small-cell lung cancer.
    Negoro S; Fukuoka M; Masuda N; Takada M; Kusunoki Y; Matsui K; Takifuji N; Kudoh S; Niitani H; Taguchi T
    J Natl Cancer Inst; 1991 Aug; 83(16):1164-8. PubMed ID: 1653362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between the pharmacokinetics of irinotecan and diarrhea during combination chemotherapy with cisplatin.
    Kudoh S; Fukuoka M; Masuda N; Yoshikawa A; Kusunoki Y; Matsui K; Negoro S; Takifuji N; Nakagawa K; Hirashima T
    Jpn J Cancer Res; 1995 Apr; 86(4):406-13. PubMed ID: 7775263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I study of irinotecan and cisplatin with granulocyte colony-stimulating factor support for advanced non-small-cell lung cancer.
    Masuda N; Fukuoka M; Kudoh S; Kusunoki Y; Matsui K; Nakagawa K; Hirashima T; Tamanoi M; Nitta T; Yana T
    J Clin Oncol; 1994 Jan; 12(1):90-6. PubMed ID: 7505810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A late phase II study of CPT-11 (irinotecan) in advanced breast cancer. CPT-11 Study Group on Breast Cancer].
    Taguchi T; Tominaga T; Ogawa M; Ishida T; Morimoto K; Ogawa N
    Gan To Kagaku Ryoho; 1994 Jun; 21(7):1017-24. PubMed ID: 8210251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I and pharmacokinetic study of the camptothecin derivative irinotecan, administered on a weekly schedule in cancer patients.
    de Forni M; Bugat R; Chabot GG; Culine S; Extra JM; Gouyette A; Madelaine I; Marty ME; Mathieu-Boué A
    Cancer Res; 1994 Aug; 54(16):4347-54. PubMed ID: 8044782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of chemotherapy using irinotecan (CPT-11) against recurrent colorectal cancer].
    Nishimura G; Satou T; Yoshimitsu Y; Kurosaka Y; Fujimura T; Sugiyama K; Kanno M; Yonemura Y; Miwa K; Miyazaki I
    Gan To Kagaku Ryoho; 1995 Jan; 22(1):93-7. PubMed ID: 7826085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.